Galectin Therapeutics, Inc. – Investigating Potential Claims
Are you concerned about your investment in Galectin Therapeutics Inc.? If so, the securities attorneys at The White Law Group may be able to help you by filing a FINRA Dispute Resolution claim against the brokerage firm that sold you the investment.
Galectin Therapeutics Inc., formerly Pro-Pharmaceuticals, Inc., is a development-stage company. The Company is engaged in drug development to create therapies for cancer and fibrotic disease, according to its website.
The company filed a Form D to raise capital from investors in 2016, according to filings with the SEC. The total offering amount was purportedly $12,000,000.
Filing a Complaint against your Brokerage Firm
The White Law Group is investigating the liability that FINRA registered brokerage firms may have for improperly recommending high-risk investments to investors.
The problem with medical technology or pharmaceutical investments such as Galectin Therapeutics Inc. is that they typically involve a high degree of risk. The research and development process for tech companies often involves costly and lengthy clinical testing trials that yield specific data. If the expected data or end points are not met, that could be bad news for investors.
Without a strong understanding of the company and its basic operations, investors may be looking at serious losses.
Broker dealers are required to perform adequate due diligence on any investment they recommend and to ensure that all recommendations are suitable for the investor. Firms that fail to do so, may be held responsible for any losses in a FINRA arbitration claim.
If you have concerns regarding investment losses in Galectin Therapeutics Inc. please call the securities attorneys at The White Law Group for a free consultation at 888-637-5510.
The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois and Franklin, Tennessee.
For more information on The White Law Group and its representation of investors in FINRA arbitration claims, visit https://www.whitesecuritieslaw.com.
Tags: Galectin Therapeutics Inc. class action, Galectin Therapeutics Inc. investment losses, Galectin Therapeutics Inc. news, Galectin Therapeutics Inc. shareholders, Galectin Therapeutics Inc. update, Galectin Therapeutics Inc. complaints, Galectin Therapeutics Inc. investigation, Galectin Therapeutics Inc. lawsuit Last modified: August 19, 2020